NCT06400459View on ClinicalTrials.gov

IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

October 15, 2024

Study Completion Date

October 15, 2024

Conditions
Dry Eye Disease
Interventions
DRUG

IVW-1001 Ophthalmic Eyelid Wipe 0.1%

IVW-1001 Ophthalmic Eyelid Wipe 0.1%

DRUG

IVW-1001 Ophthalmic Eyelid Wipe 0.2%

IVW-1001 Ophthalmic Eyelid Wipe 0.2%

DRUG

IVW-1001 Placebo

IVW-1001 Placebo

Trial Locations (1)

77025

Houston Eye Associates, Houston

Sponsors
All Listed Sponsors
lead

IVIEW Therapeutics Inc.

INDUSTRY